APA (7th ed.) Citation

SH, A., D, B., KJ, K., J, C., H, Y., CY, J., . . . N, H. (2026). Risk of Cardiovascular Events in Patients with Osteoporosis on Romosozumab Treatment Compared with Denosumab: A Multicenter Observational Cohort Study. Endocrinology and metabolism (Seoul, Korea). https://doi.org/10.3803/EnM.2026.2883

Chicago Style (17th ed.) Citation

SH, Ahn, Boo D, Kim KJ, Choi J, Yoon H, Jung CY, You SC, Oh JS, and Hong N. "Risk of Cardiovascular Events in Patients with Osteoporosis on Romosozumab Treatment Compared with Denosumab: A Multicenter Observational Cohort Study." Endocrinology and Metabolism (Seoul, Korea) 2026. https://doi.org/10.3803/EnM.2026.2883.

MLA (9th ed.) Citation

SH, Ahn, et al. "Risk of Cardiovascular Events in Patients with Osteoporosis on Romosozumab Treatment Compared with Denosumab: A Multicenter Observational Cohort Study." Endocrinology and Metabolism (Seoul, Korea), 2026, https://doi.org/10.3803/EnM.2026.2883.